
Aperio Lifescience Private Limited
About Aperio Lifescience Private Limited
Data last updated:
Aperio Lifescience Private Limited is a private limited company based in Surat, Gujarat, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 11 September 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24233GJ2013PTC076765. Its GSTIN is 24AALCA9758P1ZR (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Naveen Kumar and Sandeep.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Pl No 25 East Part Jalaram Nagar Soc. Near Patel Nagar Udhna, Surat, Gujarat, India – 394210.
As per the financials filed for FY 2019, the company reported a revenue of ₹17.02 Lakh, a decline of 31% compared to the previous year. For the same year it recorded a net profit of ₹12,546 (net margin 0.7%) and EBITDA of ₹30,407 (EBITDA margin 1.8%). Revenue has declined at a compounded annual rate (CAGR) of 18% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Aperio Lifescience Private Limited's registered office is in Surat, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPl No 25 East Part Jalaram Nagar Soc. Near Patel Nagar Udhna, Surat, Gujarat, India – 394210
- IndustryTrading, Other Wholesale, Retail Trading, Wholesale, Retailers
To see the full contact details of Aperio Lifescience Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aperio Lifescience is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Aperio Lifescience Private Limited, buy the company report.
Financials of Aperio Lifescience Private Limited
FY 2019 filings availableAperio Lifescience Private Limited reported revenue of ₹17.02 Lakh (down 31% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 18% over three years, including a 31% fall in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹30,407 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12,546 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.8% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aperio Lifescience Private Limited, buy the company report.
Board of directors of Aperio Lifescience Private Limited
Aperio Lifescience has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naveen Kumar Also directs: Dynamic Buildworks Private Limited | Director | 11 Sep 2013 | 13 Years 2 Months | Current |
| Sandeep | Director | 08 Sep 2021 | 5 Years 2 Months | Current |
Peer comparison
Aperio Lifescience Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Asit Infotech Private Limited | ₹17.03 Lakh (FY 2020) | -17.0% | Sunder Nagar, Himachal Pradesh, India | |||
| Swesh Agro India Private Limited | ₹17.03 Lakh (FY 2025) | -9.0% | Siliguri, West Bengal, India | |||
| Evfortune Charging Solutions Private Limited | ₹17.03 Lakh (FY 2025) | 121.0% | Pune, Maharashtra, India | |||
| Cobnet Steels Private Limited | ₹17.02 Lakh (FY 2024) | -39.0% | New Delhi, Delhi, India | |||
| Vinayak Plywood & Furniture House Private Limited | ₹17.02 Lakh (FY 2023) | 11.0% | Surajgarh, Rajasthan, India | |||
| Aperio Lifescience Private Limitedthis company | ₹17.02 Lakh (FY 2019) | ₹12,546 | 0.7% | -31.0% | Surat, Gujarat, India | |
| F C Trade Links Private Limited | ₹17.02 Lakh (FY 2025) | -17.0% | Himachal Pradesh, India | |||
| Trichy-Ravi Remedy Drugs Private Limited | ₹17.02 Lakh (FY 2018) | Tiruchirappalli, Tamil Nadu, India | ||||
| Patel Stationers Private Limited | ₹17.02 Lakh (FY 2023) | 15.0% | Mumbai, Maharashtra, India | |||
| Mediwing Pharmaceuticals Private Limited | ₹17.02 Lakh (FY 2016) | -5.0% | Ernakulam, Kerala, India | |||
| JSW Natural Resources Bengal Limited | ₹17.01 Lakh (FY 2025) | -48.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Aperio Lifescience Private Limited, buy the company report.
Auditor
Aperio Lifescience Private Limited is audited by BAKALE & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BAKALE & CO | FY 2017 | 009900S |
Shareholding
The shareholding of Aperio Lifescience Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Aperio Lifescience Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aperio Lifescience Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aperio Lifescience Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aperio Lifescience has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AALCA9758P1ZR | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Aperio Lifescience Private Limited, buy the company report.
Recent activity
Aperio Lifescience Private Limited has 5 board changes on record since 2013: 2 appointments and 3 cessations. The latest: Parvesh Kumar ceased to be Director on 10 Sep 2021.
Frequently asked questions
Aperio Lifescience is an active private limited company based in Surat, Gujarat, India. The company works in other wholesale, within the trading industry. It was incorporated on 11 September 2013 (13+ years old) and is registered under CIN U24233GJ2013PTC076765.
Aperio Lifescience has 2 current directors:
- Naveen Kumar - Director
- Sandeep - Director
The latest financial statements of Aperio Lifescience on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
The GSTIN of Aperio Lifescience is 24AALCA9758P1ZR, registered in Gujarat.
The CIN (Corporate Identification Number) of Aperio Lifescience is U24233GJ2013PTC076765. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aperio Lifescience was incorporated on 11 September 2013, making it 13+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Aperio Lifescience by revenue are Asit Infotech Private Limited, Swesh Agro India Private Limited, Evfortune Charging Solutions Private Limited, Cobnet Steels Private Limited, Vinayak Plywood & Furniture House Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Parvesh Kumar ceased to be Director on 10 Sep 2021. Sandeep was appointed as Director on 08 Sep 2021. Kapil Sharma ceased to be Director on 10 Nov 2016. Aperio Lifescience has 5 board changes on record in total.
The registered office of Aperio Lifescience is at Pl No 25 East Part Jalaram Nagar Soc. Near Patel Nagar Udhna, Surat, Gujarat, India – 394210.
Aperio Lifescience operates in the trading industry, in the other wholesale segment.
The compliance status of Aperio Lifescience is compliant as of 07 August 2026. The company is actively filing with the Registrar of Companies.

